The European life sciences and medical technology ecosystem gathered for one of the year’s most influential industry events with the celebration of LSI Europe 2024 in Portugal. Bringing together industry leaders, investors, startups, and healthcare innovators, the event once again demonstrated the growing momentum behind medical innovation across Europe.
Among the participating companies, Newmanbrain stood out as an example of how emerging technologies—particularly artificial intelligence applied to brain health—are shaping the future of healthcare.
LSI Europe: A Strategic Meeting Point for Health Innovation
LSI Europe has established itself as a key platform within the life sciences sector by focusing not only on scientific advancement but also on investment, partnerships, and business growth. The 2024 edition, held in Portugal, brought together:
- Medtech and healthtech companies in growth stages
- Specialized healthcare investors and venture capital funds
- Executives from major healthcare corporations
- Innovation leaders and research institutions
The event’s core mission is to connect innovation with capital and strategic partnerships, accelerating the path from research to real-world clinical application. This approach is particularly relevant at a time when digital health and artificial intelligence are transforming diagnostics, patient monitoring, and preventive medicine.
Newmanbrain: Spanish Innovation in Neurotechnology and AI
Representing the growing strength of innovation coming from Spain, Newmanbrain participated in the event as part of a new generation of companies working at the intersection of neuroscience, artificial intelligence, and medical technology.
The company focuses on developing objective tools for assessing cognitive health, with the aim of helping healthcare professionals identify cognitive decline at an early stage. Its Theia device, with technology that combines neurophysiological data analysis with artificial intelligence-based knowledge, addresses one of the main challenges facing modern healthcare systems: the early detection and monitoring of neurodegenerative diseases.
By presenting its solutions at LSI Europe, Newmanbrain had the opportunity to engage with international investors, industry partners, and healthcare stakeholders interested in scalable, data-driven approaches to brain health.
The Value of International Industry Events
Participation in international forums such as LSI Europe represents a crucial milestone for emerging companies. Beyond visibility, these events enable organizations to:
- Showcase technological innovation to specialized investors
- Validate solutions within international markets
- Establish collaborations with hospitals and research centers
- Explore expansion opportunities across Europe
For Newmanbrain, being part of this environment reinforced its positioning within the European medtech ecosystem and highlighted the increasing demand for solutions that integrate AI with clinical decision-making.
Europe’s Growing Leadership in Digital Health
The presence of companies like Newmanbrain reflects a broader trend: Europe continues to strengthen its position as a hub for digital health and neurotechnology innovation. Events such as LSI Europe serve as catalysts, connecting research, entrepreneurship, and investment to accelerate the adoption of next-generation healthcare solutions.
As populations age and neurological conditions become more prevalent, technologies that enable earlier detection and more precise assessment will play a central role in the future of healthcare systems worldwide.